Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.4M | 2.7M | 2.3M | 2.0M |
| Cost of revenue | 3.1M | 3.5M | 3.0M | 2.9M |
| Gross profit | 310K | -829K | -721K | -848K |
| Operating expense | ||||
| Research & development | 21.6M | 24.3M | 27.1M | 26.2M |
| Selling general and admin | 9.2M | 9.1M | 10.0M | 10.4M |
| Other operating expenses | — | — | — | — |
| Operating income | -30.4M | -34.2M | -37.9M | -37.4M |
| Non operating interest income | ||||
| Income | 1.0M | 1.4M | 1.8M | 2.1M |
| Expense | — | — | — | — |
| Other income expense | -5.4M | -3.3M | -1.3M | -8.0M |
| Pretax income | -34.8M | -36.1M | -37.4M | -43.3M |
| Tax provision | 57K | 26K | 22K | 123K |
| Net income | -34.9M | -36.1M | -37.4M | -43.4M |
| Basic EPS | -0.6 | -0.7 | -0.7 | -0.8 |
| Diluted EPS | -0.6 | -0.7 | -0.7 | -0.8 |
| Basic average shares | 54.8M | 54.0M | 53.7M | 53.0M |
| Diluted average shares | 54.8M | 54.0M | 53.7M | 53.0M |
| EBITDA | -28.1M | -32.0M | -35.6M | -23.7M |
| Net income from continuing op. | -34.9M | -36.1M | -37.4M | -43.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |